Group One Trading’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-200
| Closed | -$19.7K | – | 8330 |
|
|
2025
Q2 | $19.7K | Buy |
+200
| New | +$18.9K | ﹤0.01% | 6268 |
|
|
2025
Q1 | – | Sell |
-5,100
| Closed | -$463K | – | 7524 |
|
|
2024
Q4 | $463K | Buy |
5,100
+4,800
| +1,600% | +$441K | ﹤0.01% | 3231 |
|
|
2024
Q3 | $29K | Hold |
300
| – | – | ﹤0.01% | 5015 |
|
|
2024
Q2 | $27.5K | Hold |
300
| – | – | ﹤0.01% | 4983 |
|
|
2024
Q1 | $27.6K | Sell |
300
-2,500
| -89% | -$234K | ﹤0.01% | 5178 |
|
|
2023
Q4 | $266K | Buy |
2,800
+1,900
| +211% | +$177K | ﹤0.01% | 3601 |
|
|
2023
Q3 | $84.1K | Buy |
900
+200
| +29% | +$18.5K | ﹤0.01% | 4614 |
|
|
2023
Q2 | $64K | Sell |
700
-600
| -46% | -$49.2K | ﹤0.01% | 5048 |
|
|
2023
Q1 | $95.6K | Sell |
1,300
-14,300
| -92% | -$1.24M | ﹤0.01% | 4338 |
|
|
2022
Q4 | $1.3M | Buy |
15,600
+15,500
| +15,500% | +$1.4M | ﹤0.01% | 2190 |
|
|
2022
Q3 | $10K | Sell |
100
-2,700
| -96% | -$322K | ﹤0.01% | 6474 |
|
|
2022
Q2 | $294K | Sell |
2,800
-7,400
| -73% | -$945K | ﹤0.01% | 3924 |
|
|
2022
Q1 | $1.76M | Buy |
10,200
+10,000
| +5,000% | +$1.49M | ﹤0.01% | 2529 |
|
|
2021
Q4 | $32K | Sell |
200
-1,100
| -85% | -$177K | ﹤0.01% | 6663 |
|
|
2021
Q3 | $194K | Buy |
+1,300
| New | +$270K | ﹤0.01% | 5206 |
|
|
2021
Q2 | – | Sell |
-11,500
| Closed | -$3.04M | – | 8097 |
|
|
2021
Q1 | $3.04M | Buy |
11,500
+8,100
| +238% | +$2.28M | ﹤0.01% | 2020 |
|
|
2020
Q4 | $997K | Sell |
3,400
-400
| -11% | -$103K | ﹤0.01% | 2644 |
|
|
2020
Q3 | $898K | Buy |
+3,800
| New | +$864K | ﹤0.01% | 2299 |
|
|
2020
Q2 | – | Sell |
-1,300
| Closed | -$239K | – | 5745 |
|
|
2020
Q1 | $239K | Sell |
1,300
-12,600
| -91% | -$2.24M | ﹤0.01% | 2613 |
|
|
2019
Q4 | $2.32M | Sell |
13,900
-29,800
| -68% | -$4.43M | 0.02% | 1179 |
|
|
2019
Q3 | $5.72M | Buy |
43,700
+30,500
| +231% | +$3.97M | 0.05% | 509 |
|
|
2019
Q2 | $1.6M | Buy |
13,200
+11,600
| +725% | +$1.38M | 0.01% | 1249 |
|
|
2019
Q1 | $197K | Buy |
+1,600
| New | +$201K | ﹤0.01% | 2717 |
|
|
2018
Q3 | – | Sell |
-14,000
| Closed | -$1.2M | – | 5145 |
|
|
2018
Q2 | $1.2M | Buy |
+14,000
| New | +$1.03M | 0.01% | 1542 |
|
|
2017
Q4 | – | Sell |
-5,000
| Closed | -$280K | – | 4799 |
|
|
2017
Q3 | $280K | Buy |
+5,000
| New | +$264K | ﹤0.01% | 2519 |
|
|
2013
Q3 | – | Sell |
-16,400
| Closed | -$191K | – | 5144 |
|
|
2013
Q2 | $191K | Buy |
+16,400
| New | +$188K | ﹤0.01% | 2214 |
|
Other funds holding AMED
IA
MCI
HNB
Group One Trading's AMED Position: Q3 2025 in Review
Group One Trading sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,555 shares — an estimated $350K sold.
Group One Trading first reported a position in AMED in Q3 2013 and held it in 22 quarters. The position peaked at $1.9M in Q3 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Group One Trading reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Group One Trading sold 3,555 Amedisys shares in Q3 2025, an estimated $350K.
- Group One Trading first reported a position in Amedisys in Q3 2013 and held it in 22 quarters.
- Group One Trading's Amedisys position peaked at $1.9M in Q3 2023.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.